| 30.03.2023 22:03:16 | |
|---|---|
| Cena | |
| 105,92 USD | |
| Změna | 0,95% (1,00) |
Základní údaje
| ISIN | US58933Y1055 |
| Symbol | MRK |
| Burza | NYSE |
| Měna | USD |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 247.680 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 103,92 USD (100) |
| Prodej (částka) | 106,16 USD (100) |
| Otevírací cena | 105,12 USD |
| Max | 106,20 USD |
| Min | 104,54 USD |
| Závěrečná cena (předchozí den) | 104,92 USD |
| Cena vážená obchodovaným objemem | 105,627717 USD |
| Objem (kusy) | 5.017.385 |
| Obchodovaný objem | 529.905.707,44 |
| Počet obchodů | 58.171 |
| Poslední zobchodovaný počet | 780.609 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: MERCK & CO. INC. |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 28.03.2023 |
|
Global Equity Ratings |
|
| 16.03.2023 |
|
Global Equity Ratings |
|
| 10.03.2023 |
|
Global Equity Ratings |
|
| 27.02.2023 |
|
Global Equity Ratings |
|
| 07.02.2023 |
|
Global Equity Ratings |
|
Všechny burzy pro MERCK & CO. INC.
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 30.03.2023 | 17:35 | 97,00 EUR | 0,03 | 14 |
| Vienna Stock Exchange | 30.03.2023 | 17:32 | 97,00 EUR | 0,00 | 1 |
| Tradegate | 30.03.2023 | 22:26 | 97,20 EUR | 0,38 | 60 |
| Stuttgart | 30.03.2023 | 21:05 | 97,00 EUR | 0,01 | 7 |
| SIX Swiss Exchange | 03.02.2020 | 17:36 | 75,00 USD | 0,00 | 1 |
| SIX Swiss Exchange | 05.12.2022 | 17:36 | 400,00 CHF | 0,00 | 1 |
| NYSE | 30.03.2023 | 22:03 | 105,92 USD | 529,91 | 58.171 |
| Munich | 30.03.2023 | 08:01 | 96,70 EUR | 0,00 | 1 |
| London Stock Exchange | 30.03.2023 | 17:35 | 105,66 USD | 0,00 | 5 |
| Hanover | 30.03.2023 | 08:09 | 96,70 EUR | 0,00 | 1 |
| Hamburg | 30.03.2023 | 08:01 | 96,70 EUR | 0,00 | 1 |
| Frankfurt | 30.03.2023 | 17:33 | 97,00 EUR | 0,03 | 6 |
| Euronext Paris | 30.03.2023 | 17:29 | 97,50 EUR | 0,02 | 7 |
| Duesseldorf | 30.03.2023 | 21:00 | 96,70 EUR | 0,00 | 12 |
| Berlin | 30.03.2023 | 20:21 | 97,00 EUR | 0,00 | 16 |
| BX Swiss | 07.03.2023 | 18:00 | 104,082 CHF | 0,00 | 1 |
| 30.03.2023 22:03:16 | |
|---|---|
| Cena | |
| 105,92 USD | |
| Změna | 0,95% (1,00) |
Základní údaje
| ISIN | US58933Y1055 |
| Symbol | MRK |
| Burza | NYSE |
| Měna | USD |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 247.680 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 103,92 USD (100) |
| Prodej (částka) | 106,16 USD (100) |
| Otevírací cena | 105,12 USD |
| Max | 106,20 USD |
| Min | 104,54 USD |
| Závěrečná cena (předchozí den) | 104,92 USD |
| Cena vážená obchodovaným objemem | 105,627717 USD |
| Objem (kusy) | 5.017.385 |
| Obchodovaný objem | 529.905.707,44 |
| Počet obchodů | 58.171 |
| Poslední zobchodovaný počet | 780.609 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +22,99% | +28,54% | +37,65% |
| Výkonn. (abs.) | +19,80 | +23,52 | +28,97 |
| Beta | 0,25 | 0,29 | 0,41 |
| Volatilita | 21,53 | 21,12 | 22,85 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 105,62 USD (6.441.032) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 107,22 USD (8.910.719) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 107,67 USD (8.985.917) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 96,95 USD (9.742.826) |
| YTD Max| datum | 115,49 USD (06.01.2023) |
| YTD Min | datum | 96,36 USD (24.01.2023) |
| 52týdenní max. | datum | 115,49 USD (06.01.2023) |
| 52týdenní min. | datum | 81,64 USD (01.04.2022) |
Logo společnosti
Kontakty
| MERCK & CO. INC. |
| - - |
| 2000 Galloping Hill Road - 07033 Kenilworth |
| Telefon:+1-908-740-4000 |
| Fax:+ |
| E-mail:- |
PDF ke stažení
| Report společnosti: MERCK & CO. INC. | |
Profil společnosti
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ. |
Členové představenstva
| Christine Seidman | Member of Board of Directors |
| Paul Rothman | Member of Board of Directors |
| Risa Lavizzo-Mourey | Member of Board of Directors |
| Stephen Mayo | Member of Board of Directors |
| Douglas Baker | Member of Board of Directors |
| Inge Thulin | Member of Board of Directors |
| Kathy Warden | Member of Board of Directors |
| Mary Coe | Member of Board of Directors |
| Pamela Craig | Member of Board of Directors |
| Patricia Russo | Member of Board of Directors |
| Peter Wendell | Member of Board of Directors |
| Thomas Glocer | Member of Board of Directors |
| Robert Davis | Chairman of Managing Board |
| Dean Li | Member of Executive Committee |
| Eric Rubin | Member of Executive Committee |
| Fiona Marshall | Member of Executive Committee |
| Allan Gabor | Member of Executive Committee |
| Andre Musto | Member of Executive Committee |
| Brooke Hinkson | Member of Executive Committee |
| Carol Bowden | Member of Executive Committee |
| Caroline Litchfield | Member of Executive Committee |
| Chirfi Guindo | Member of Executive Committee |
| Dave Williams | Member of Executive Committee |
| Denise Williams | Member of Executive Committee |
| Jacks Lee | Member of Executive Committee |